Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 30, 2025 | (FY)Mar 30, 2024 | (FY)Mar 30, 2023 | (FY)Mar 30, 2022 | (FY)Mar 30, 2021 | (FY)Mar 30, 2020 | (FY)Mar 30, 2019 | (FY)Mar 30, 2018 | (FY)Mar 30, 2017 | (FY)Mar 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 76.40%-2.4M | -378.13%-10.15M | 60,209.95%3.65M | -100.06%-6.07K | 100.24%10.18M | 168.57%5.08M | -0.51%-7.41M | -0.77%-7.38M | -329.84%-7.32M | 3.18M |
| Other cash income from operating activities | 76.40%-2.4M | -378.13%-10.15M | 60,209.95%3.65M | -100.06%-6.07K | 100.24%10.18M | 168.57%5.08M | -0.51%-7.41M | -0.77%-7.38M | -329.84%-7.32M | --3.18M |
| Cash paid | ||||||||||
| Direct dividend received | 63.48%129.73K | -47.87%79.35K | -11.61%152.22K | -59.51%172.23K | -34.37%425.35K | -51.34%648.14K | 94.59%1.33M | 42.26%684.46K | 49.07%481.12K | --322.76K |
| Direct interest paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.77%-83.32K | 73.02%-41.71K | ---154.59K |
| Direct interest received | -41.42%137.03K | -47.39%233.93K | 287.99%444.64K | 62.25%114.6K | -65.96%70.63K | -41.95%207.52K | -23.48%357.47K | 1,302.46%467.15K | -97.19%33.31K | --1.19M |
| Direct tax refund paid | 48.49%-71.27K | 77.10%-138.36K | 38.42%-604.25K | -104.07%-981.17K | -92.44%-480.79K | 56.46%-249.84K | -86.66%-573.8K | 79.20%-307.4K | -78.88%-1.48M | ---826.17K |
| Operating cash flow | 77.95%-2.2M | -373.90%-9.98M | 620.14%3.64M | -106.87%-700.41K | 79.18%10.19M | 190.34%5.69M | 4.79%-6.3M | 20.54%-6.61M | -345.57%-8.32M | --3.39M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 97.32%-133.63K | -108.59%-4.98M | 35.98%-2.39M | -572.32%-3.73M | -119.90%-555.14K | -33.91%2.79M | 44.62%4.22M | -37.05%2.92M | 757.03%4.64M | -705.53K |
| Capital expenditure reported | ---- | ---- | -9.29%-1.38M | -86.94%-1.26M | ---673.1K | ---- | ---- | ---- | ---- | ---- |
| Net PPE purchase and sale | ---- | ---- | 90.97%-220.74K | -320.49%-2.44M | -192.72%-581.44K | 47.40%-198.63K | 38.42%-377.65K | -13.19%-613.28K | -6.15%-541.81K | ---510.43K |
| Net intangibles purchas and sale | ---- | ---- | -9.29%-1.38M | -86.94%-1.26M | -65.88%-673.1K | -66.18%-405.78K | ---244.18K | ---- | ---- | ---- |
| Net business purchase and sale | ---- | -10,897.70%-4.91M | ---44.68K | ---- | ---- | 105.23%161.51K | -133.01%-3.09M | -11.53%9.36M | 636.67%10.57M | ---1.97M |
| Net investment purchase and sale | ---133.63K | ---- | -942.40%-356.4K | -320.75%-34.19K | -103.53%-8.13K | 122.13%230.1K | -1,068.90%-1.04M | -106.34%-88.96K | -3.47%1.4M | --1.45M |
| Dividends received (cash flow from investment activities) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --322.76K |
| Net other investing changes | ---- | 82.16%-70K | -7,807.11%-392.45K | -99.28%5.09K | -77.30%707.53K | -65.25%3.12M | 256.40%8.97M | 15.65%-5.74M | ---6.8M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 97.32%-133.63K | -108.59%-4.98M | 35.98%-2.39M | -572.32%-3.73M | -119.90%-555.14K | -33.91%2.79M | 44.62%4.22M | -37.05%2.92M | 757.03%4.64M | ---705.53K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 89.85%-132K | 80.53%-1.3M | -268.62%-6.68M | 460.68%3.96M | 59.18%-1.1M | -885.93%-2.69M | -93.48%342.29K | 311.32%5.25M | 55.64%-2.49M | -5.6M |
| Net issuance payments of debt | ---- | 40.27%-198.04K | -145.35%-331.57K | --731.17K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net common stock issuance | ---- | ---505.73K | ---- | 25.38%-360.73K | -1,250.02%-483.39K | -152.24%-35.81K | --68.54K | ---- | -16.21%-286.71K | ---246.73K |
| Cash dividends paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 47.42%-1.12M | 60.06%-2.14M | ---5.36M |
| Interest paid (cash flow from financing activities) | 93.79%-4.89K | 48.32%-78.83K | -31.37%-152.54K | -244.25%-116.12K | 58.65%-33.73K | -393.46%-81.57K | ---16.53K | ---- | ---- | ---- |
| Net other financing activities | 87.72%-127.11K | 85.21%-1.04M | -355.18%-7M | 252.41%2.74M | 54.60%-1.8M | -1,270.24%-3.97M | -94.65%338.84K | 5,438.90%6.34M | ---118.68K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 89.85%-132K | 80.53%-1.3M | -268.62%-6.68M | 460.68%3.96M | 59.18%-1.1M | -885.93%-2.69M | -93.48%342.29K | 311.32%5.25M | 55.64%-2.49M | ---5.6M |
| Net cash flow | ||||||||||
| Beginning cash position | -79.33%4.22M | -22.55%20.41M | -1.76%26.35M | 45.42%26.82M | 48.94%18.44M | -12.29%12.38M | 12.39%14.12M | -32.96%12.56M | -13.48%18.74M | --21.66M |
| Current changes in cash | 84.83%-2.47M | -199.78%-16.26M | -1,049.02%-5.42M | -105.53%-472.13K | 47.56%8.54M | 433.55%5.79M | -211.54%-1.74M | 125.20%1.56M | -111.52%-6.18M | ---2.92M |
| Effect of exchange rate changes | -130.06%-22.45K | 114.45%74.68K | -105,151.02%-516.85K | 100.30%492 | -160.55%-164.12K | --271.04K | ---- | ---- | ---- | ---- |
| End cash Position | -59.00%1.73M | -79.33%4.22M | -22.55%20.41M | -1.76%26.35M | 45.42%26.82M | 48.94%18.44M | -12.29%12.38M | 12.39%14.12M | -32.96%12.56M | --18.74M |
| Free cash from | 77.95%-2.2M | -1,585.03%-9.98M | 111.87%671.93K | -168.54%-5.66M | 62.46%8.26M | 173.49%5.09M | 4.27%-6.92M | 18.51%-7.23M | -408.02%-8.87M | --2.88M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |